Xenon Pharmaceuticals Inc XENE
$62.35
-2.93%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-08-13 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 8-K | 8-K | 2026-06-03 | View → |
| 4 | 4 | 2026-05-13 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-22 | View → |
| 8-K | 8-K | 2026-04-13 | View → |
| 4 | 4 | 2026-03-13 | View → |
| 4 | 4 | 2026-03-13 | View → |
| 4 | 4 | 2026-03-13 | View → |
| 8-K | 8-K | 2026-03-13 | View → |
| 8-K | 8-K | 2026-03-12 | View → |
| 424B5 | 424B5 | 2026-03-12 | View → |
| 4 | 4 | 2026-03-11 | View → |
| 4 | 4 | 2026-03-11 | View → |
| 4 | 4 | 2026-03-11 | View → |
| 424B5 | 424B5 | 2026-03-09 | View → |
| 8-K | 8-K | 2026-03-09 | View → |
| 8-K | 8-K | 2026-02-27 | View → |
| 424B5 | 424B5 | 2026-02-27 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
| 4 | 4 | 2026-01-09 | View → |
| 4 | 4 | 2026-01-09 | View → |
| 4 | 4 | 2026-01-09 | View → |
| 4 | 4 | 2026-01-09 | View → |
| 4 | 4 | 2026-01-02 | View → |
| 4 | 4 | 2025-12-09 | View → |
| 4 | 4 | 2025-12-03 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $62.35
- Market Cap
- $6.31 billion
- 52-Week Range
- $30.00 – $72.66
- Average Volume
- 1.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.